FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Resources - All Kinds, Realm US, Authority Hl7

19,239 resources

Type: Text:

By Version

 

Start Prev Rows 7400 - 7600 Next

PackageVersionIdentityName/TitleStatusFMMWGDate
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1029.388.jsonPlacenta Increta or Percretaactive2024-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.10.jsonNon essential Hypertension SNOMEDCTactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.12.jsonCirrhosis ICD10CMactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.151.jsonPolycystic Ovary Syndromeactive2023-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.16.jsonLow Intensity Statin Therapy/Brandedactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.17.jsonModerate Intensity Statin Therapy/Brandedactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.18.jsonHigh Intensity Statin Therapy/Brandedactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.233.jsonAll Results of High Risk HPV Testactive2023-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.234.jsonHigh Risk HPV Positive Resultsactive2023-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.263.jsonHigh Risk Positive HPV Results Without HPV16 or HPV18active2023-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.268.jsonHPV Negative Resultsactive2023-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.27.jsonNon pharmacologic treatments for chronic pain ICD10PCSactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.29.jsonNon pharmacologic treatments for chronic pain SCTactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.298.jsonCervical Cytology Testactive2023-08
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.299.jsonHPV 16 Testsactive2023-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.300.jsonHPV 18 Testsactive2023-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.305.jsonCounseling for Physical Activity CPTactive2024-01
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.306.jsonCounseling for Physical Activity ICD10CMactive2024-01
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.307.jsonCounseling for Physical Activity CDSactive2024-01
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.322.jsonTest 123active2025-01
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.34.jsonOpioid pain medicationsactive2023-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.36.jsonNon pharmacologic treatments for chronic painactive2023-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.40.jsonSuicide attemptactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.42.jsonNaloxone and Nalmefene medicationsactive2024-01
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.43.jsonBenzodiazepine medicationsactive2024-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.44.jsonStool softeners and laxativesactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.47.jsonAnxietyactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.48.jsonAnxietyactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.50.jsonSleep disordered breathingactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.51.jsonSleep disordered breathingactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.52.jsonAnxietyactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.53.jsonSleep disordered breathingactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.54.jsonAdjuvant pain medicationsactive2023-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.6.jsonNon essential Hypertension ICD9CMactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.7.jsonNon essential Hypertension ICD10CMactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.79.jsonBehavioral Counseling for Nutrition and Activity Referralactive2023-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.85.jsonImpaired Glucose Toleranceactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.87.jsonFasting Plasma Glucoseactive2023-05
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.88.jsonWaist Circumferenceactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.9.jsonHypertensionactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.92.jsonFirst Degree Family Memberactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1032.94.jsonGlucose Tolerance Test Resultsactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.555.jsonPatient Declines Treatment for Cluster Headache (SNOMEDCT)active2025-05
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.558.jsonAcute Cluster Headache Medication (RXNORM)active2025-05
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.559.jsonLong Term Preventive Medication for Cluster Headacheactive2023-12
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.569.jsonMigraine Preventive Medicationactive2023-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.601.jsonAcute Migraine Attack Medicationactive2025-05
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.605.jsonNSAID OTC Migraine Attack Medicationactive2023-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.606.jsonNSAID Prescribable Migraine Attack Medicationactive2025-05
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.641.jsonNeuromodulation for migraineactive2023-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.642.jsonNo pain with headacheactive2023-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.643.jsonAntiplateletsactive2023-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.644.jsonAnticoagulantsactive2023-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.645.jsonStatin Medicationsactive2023-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.646.jsonAnxiety Disorders (ICD10 and SNOMED)active2023-10
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.648.jsonDepression Diagnosis (ICD10 and SNOMED)active2023-10
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.649.jsonPsychosis (ICD10 and SNOMED)active2023-10
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.650.jsonCluster Headache (SNOMED)active2023-12
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.651.jsonGalcanezumab (RxNorm)active2023-12
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.652.jsonLithium (RxNorm)active2023-12
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.653.jsonVerapamilactive2023-12
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.654.jsonLong term preventive medications for cluster headacheactive2023-12
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.655.jsonShort term preventive medication for cluster headacheactive2023-12
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.656.jsonZolmitriptanactive2023-12
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.657.jsonSumatriptanactive2023-12
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.658.jsonDihydroergotamineactive2023-12
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.659.jsonAcute cluster headache medicationactive2023-12
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.660.jsonAcute cluster headache treatmentactive2023-12
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.661.jsonShort term preventive treatment for cluster headacheactive2023-12
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.662.jsonLong term preventive treatment for cluster headacheactive2023-12
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.663.jsonMigraine diagnosis (ICD)active2025-05
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.664.jsonPrescribable NSAIDs and Acute Migraine Attack Medicationactive2025-05
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.103.jsonAbnormal Presentationactive2023-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.105.jsonAbnormal Presentationactive2021-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.130.jsonRespiratory Rateactive2023-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.15.jsonIntravenous Thrombolytic tPA Therapyactive2021-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.16.jsonIntraarterial Thrombolytic tPA Therapyactive2021-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.163.jsonSystolic Blood Pressureactive2023-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.171.jsonAbnormal Presentationactive2024-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.173.jsonDelivery of Singletonactive2021-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.21.jsonIntravenous or Intraarterial Thrombolytic tPA Therapyactive2022-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.26.jsonEstimated Gestational Age at Deliveryactive2021-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.27.jsonCornual Ectopic Pregnancyactive2021-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.38.jsonGeneral Or Neuraxial Anesthesiaactive2021-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.39.jsonLow Dose Unfractionated Heparin for VTE Prophylaxisactive2024-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.41.jsonGlycoprotein IIb IIIa Inhibitorsactive2023-01
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.55.jsonOxytocinactive2021-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.56.jsonDinoprostoneactive2025-05
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.58.jsonDelivery Proceduresactive2021-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.59.jsonDelivery Proceduresactive2022-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.67.jsonPCIactive2022-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.68.jsonEndotracheal Intubationactive2018-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.69.jsonEndotracheal Intubationactive2025-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.98.jsonDelivery of Singletonactive2021-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.99.jsonDelivery of Singletonactive2021-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1046.225.jsonOpioid Medication Assisted Treatment (MAT) SNOMEDactive2024-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1046.241.jsonSchedule II, III and IV Opioid Medicationsactive2024-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1046.242.jsonOpioid Use Disorderactive2024-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1046.243.jsonOpioid Use Disorderactive2024-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1046.265.jsonInpatient, Emergency, and Observation Locationsactive2022-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1046.269.jsonMedications for Opioid Use Disorder (MOUD)active2024-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1046.274.jsonNHSN Inpatient Encounter Class Codesactive2024-04
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1046.277.jsonEmergency Department Locationactive2024-04
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1046.278.jsonEmergency Department Treatment Locationactive2025-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1046.283.jsonEmergency Department Locationactive2024-04
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1046.284.jsonEmergency Department Locationactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1046.285.jsonMental Health Diagnosis without Substance Use Disordersactive2024-09
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1046.286.jsonDecision to Transferactive2024-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1046.35.jsonHealthcare Agent or Proxy Choicesactive2022-10
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.10.jsonBreastfeedingactive2025-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.100.jsonFamilial Hypercholesterolemiaactive2021-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.102.jsonRhabdomyolysisactive2017-05
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.107.jsonLow Intensity Statin Therapyactive2025-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.12.jsonLiver Diseaseactive2025-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.13.jsonRhabdomyolysisactive2025-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.19.jsonAtherosclerosis and Peripheral Arterial Diseaseactive2025-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.20.jsonAtherosclerosis and Peripheral Arterial Diseaseactive2025-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.21.jsonAtherosclerosis and Peripheral Arterial Diseaseactive2024-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.22.jsonLiver Disease ICD9active2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.37.jsonStable and Unstable Anginaactive2025-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.39.jsonCerebrovascular Disease Stroke or TIAactive2023-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.41.jsonIschemic Heart Disease or Related Diagnosesactive2025-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.42.jsonLiver Diseaseactive2022-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.43.jsonLiver Diseaseactive2021-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.44.jsonCerebrovascular Disease Stroke or TIAactive2024-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.46.jsonIschemic Heart Disease or Related Diagnosesactive2024-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.47.jsonStable and Unstable Anginaactive2024-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.501.jsonOverweight or Obeseactive2025-01
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.502.jsonOverweight or Obeseactive2018-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.512.jsonElevated Blood Pressure Readingactive2019-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.513.jsonElevated Blood Pressure Readingactive2020-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.514.jsonFinding of Elevated Blood Pressure or Hypertensionactive2019-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.515.jsonBariatric Proceduresactive2024-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.517.jsonAge related macular degeneration intermediate dryactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.518.jsonOphthalmologist visitactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.519.jsonPosterior vitreous detachment (PVD)active2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.521.jsonOphthalmoscopic examactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.523.jsonOpthalmoscopic exams with Scleral Depressionactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.525.jsonReferral (ophthalmology)active2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.526.jsonRetina Ultrasoundactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.527.jsonRetina visualization inadequateactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.528.jsonRefusal or Noncompliance with treatmentactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.529.jsonVitreous hemorrhageactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.530.jsonVitreous hemorrhageactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.536.jsonMacula examinationactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.539.jsonFluorescein angiographyactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.541.jsonOptical coherence tomography (OCT)active2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.542.jsonIntravitreal injectionactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.543.jsonBevacizumab injectionactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.544.jsonRanibizumab injectionactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.545.jsonAflibercept injectionactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.552.jsonUveitisactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.553.jsonUveitisactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.554.jsonPost Cataract Surgery Cystoid Macular Edema AND Idiopathic Macular Edemaactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.555.jsonMacular edemaactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.556.jsonCorticosteroids for Injectionactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.557.jsonCorticosteroids for Injectionactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.560.jsonTonometryactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.561.jsonIntraocular pressureactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.571.jsonRetinal Vein Occlusion Related Macular Edemaactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.576.jsonVitreous hemorrhageactive2020-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.580.jsonIntravitreal and Periocular Injectionsactive2020-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.581.jsonIntravitreal and Periocular Injectionsactive2022-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.582.jsonCorticosteroids for Injectionactive2020-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.583.jsonEndophthalmitis in the Right Eyeactive2020-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.584.jsonEndophthalmitis in the Left Eyeactive2020-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.585.jsonPanophthalmitis in the Right Eyeactive2020-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.586.jsonPanophthalmitis in the Left Eyeactive2020-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.587.jsonLost to follow upactive2020-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.588.jsonUveitisactive2020-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.610.jsonScleral depressed examactive2020-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.611.json3 Mirror Goldmann examactive2020-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.612.jsonScleral depressed examactive2022-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.615.jsonPhysical Disabilityactive2020-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.616.jsonFinancial difficultyactive2020-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.617.jsonVitreous exam findingsactive2020-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.619.jsonScleral depressed examactive2020-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.629.jsonPost operative follow upactive2020-07
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.67.jsonBreastfeedingactive2017-05
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.69.jsonStable and Unstable Anginaactive2025-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.70.jsonIschemic Heart Disease or Related Diagnosesactive2021-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.71.jsonCerebrovascular Disease Stroke or TIAactive2023-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.73.jsonBreastfeedingactive2021-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.85.jsonFamilial Hypercholesterolemiaactive2023-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.89.jsonRhabdomyolysisactive2017-05
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.9.jsonOutpatient Encounters for Preventive Careactive2019-03
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.91.jsonFamilial Hypercholesterolemiaactive2021-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.93.jsonHypercholesterolemia ICD 9active2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.97.jsonHigh Intensity Statin Therapyactive2024-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.98.jsonModerate Intensity Statin Therapyactive2025-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1056.50.jsonHIV Lab Testsactive2025-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1056.51.jsonIndicators of Human Immunodeficiency Virus (HIV)active2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1056.52.jsonIndicators of Human Immunodeficiency Virus (HIV)active2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1056.53.jsonIndicators of Human Immunodeficiency Virus (HIV)active2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1056.71.jsonHuman Immunodeficiency Virus (HIV) Viral Loadactive2024-06
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.10.jsonARBs (Angiotensin Receptor Blockers)active2024-12
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1000.jsonOIA_V2_GLP1s_RxNormsactive2025-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1001.jsonOIA_V2_PCSK9s_RxNormsactive2025-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1002.jsonOIA_RFs_Secondary_Prevention_ICD10active2025-02
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1003.jsonOIA_RFs_Secondary_Prevention_SNOMEDactive2025-02